Obesity pharmacology Flashcards
Portion of hypothalamus that regulates feeding behavior
arcuate nucleus
Hormone that is released during fasting from the intestinal lining and release is inhibited when intestinal cells are stretched (food is present)
Ghrelin
POMC is cleaved and post-transcriptionally modified to generate what 2 hormones
ACTH and alpha-MSH
Hormone involved in appetite that is a MC4R agonist
alpha-MSH
Hormone involved in increasing appetite that is a MC4R antagonist
AGRP
BMI that indicates obese class III (morbid)
> 40
Excessive amount of adipose tissue compared to lean tissue
Obesity
Excessive body weight from all tissues
Overweight
Neurons whose signaling decreases feeding
POMC neurons
Neurons whose signaling increases feeling
AGRP/NYP neurons
neurons that send signals to the lateral hypothalamus to alter taste sensation and control autonomic responses to digestive secretions
Paraventricular neurons
MOA of orlistat
Inhibits lipase enzymes in the small intestine
Approved duration of treatment for phentermine
3 months
MOA of phentermine
agonist as TAAR in the hypothalamus
MOA of lorcaserin
Selective 5-HT2C receptor agonist
MOA of bupropion
Inhibits DA and NE uptake
MOA of naltrexone
mu-opioid receptor antagonist
Cells that produce and secrete leptin
adipocytes
Pathway in POMC neurons that is required for anti-obesity effect of leptin
JAK/STAT pathway
Molecule that inhibits JAK/STAT pathway as a neg feedback mechanism when there are high circulating levels of leptin
SOCS3 (suppressor of cytokine signaling 3)
MOA of metreleptin
agonist at leptin receptor (LEPRb)
MOA of pramlintide
agonist at amylin receptor
Peptide hormone co-secreted with insulin from pancreatic beta-cells that slows gastric emptying, inhibits glucagon release and promotes satiety
Amylin
5-HT2 agonists that were withdrawn from the market due to pulmonary HTN and cardiac valve defects (due to 5-HT2B activity)
Fenfluramine and dexfenfluramine
Non-selective 5-HT/NE reuptake inhibitor that was withdrawn from the market due to increased risk of MI and stroke in pts with high risk of CV disease
Sibutramine
Cannabinoid receptor inverse agonist that was withdrawn from the market due to increased risk of suicide
Rimonabant
Main source of fuel of AGRP/NPY neurons
FAs
Main source of fuel for POMC neurons
glucose
BMI that indicates overweight
25-30
BMI that indicates normal weight
18.5-25
BMI that indicates obese class II (severe)
35-40
BMI that indicates Obese class I (moderate)
30-35
BMI that indicates underweight